Tissue Regenix Group plc (AIM: TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 58.50
0.00 (0.00%)
Jan 21, 2025, 4:24 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 41.67 million as of January 22, 2025. Its market cap has increased by 16.04% in one year.
Market Cap
41.67M
Enterprise Value
46.67M
Revenue
25.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.50
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has increased from 41.00M to 41.67M, an increase of 1.63%. That is a compound annual growth rate of 0.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.45B |
| Haleon | 33.80B |
| Smith & Nephew | 8.94B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |